A tool for selecting patients with a high probability of sustained virological response to peginterferon alfa-2a (40kD)/ribavirin.

@article{Ferenci2014ATF,
  title={A tool for selecting patients with a high probability of sustained virological response to peginterferon alfa-2a (40kD)/ribavirin.},
  author={P Ferenci and Rodrigo Sebba Aires and Ioan Ancuţa and Andrew Arohnson and Hugo Cheinquer and Dragan S Delic and Michael Gschwantler and Dominique G Larrey and Ludovico Tallarico and Manuela Schmitz and Fernando Franciosi Tatsch and Denis Ouzan},
  journal={Liver international : official journal of the International Association for the Study of the Liver},
  year={2014},
  volume={34 10},
  pages={
          1550-9
        }
}
BACKGROUND & AIMS Pretreatment identification of patients likely to achieve a sustained virological response (SVR) with peginterferon alfa-2a/ribavirin would be useful for individualizing treatment choices. The aim of this analysis was to devise a simple scoring system to identify patients with high probability of achieving an SVR with peginterferon alfa-2a/ribavirin. METHODS Using data from 2109 Caucasian treatment-naive hepatitis C virus (HCV) genotype 1 mono-infected patients from the… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS